▌110-112年度
| 篇序 | 作者姓名 (順位) |
論文題目 | 論文 性質 |
期刊名稱 (年份/ 卷期/頁次) |
屬性 SCI、SSCI、IEEE |
所屬學門領域 | 所屬學門領域排名 | Impact Factor |
|---|---|---|---|---|---|---|---|---|
| 1 | 賴志政(3) | THE ASSOCIATION BETWEEN INHALED CORTICOSTEROID AND THE RISKS OF SARS-COV-2 INFECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS | Original Article |
J Infect Public Health . 2023 May;16(5):823-830. |
SCI | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | 49/392 | 7.537 |
| 2 | 賴志政(4,C) | THE ASSOCIATION BETWEEN CORTICOSTEROIDS AND ASPERGILLOSIS AMONG COVID-19 PATIENTS | Original Article |
J Infect. 2023 Apr; 86(4): 394–396. | SCI | INFECTIOUS DISEASES | 4/95 | 38.637 |
| 3 | 賴志政(5,C) | POST-ACUTE HOSPITALIZATION AND MORTALITY OF NIRMATRELVIR PLUS RITONAVIR FOR COVID-19 SURVIVORS | Original Article |
J Infect. 2023 Apr;86(4):e107-e110. | SCI | INFECTIOUS DISEASES | 4/95 | 38.637 |
| 4 | 賴志政(6,C) | THE RISK OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTION FOLLOWING COVID-19 AND INFLUENZA: A RETROSPECTIVE COHORT STUDY FROM THE TRINETX NETWORK | Original Article |
J Infect. 2023 Mar;86(3):256-308. | SCI | INFECTIOUS DISEASES | 4/95 | 38.637 |
| 5 | 賴志政(5,C) | THE EFFECT OF NIRMATRELVIR PLUS RITONAVIR ON THE LONG-TERM RISK OF EPILEPSY AND SEIZURE FOLLOWING COVID-19: A RETROSPECTIVE COHORT STUDY INCLUDING 91,528 PATIENTS | Original Article |
J Infect. 2023 Mar;86(3):256-308. | SCI | INFECTIOUS DISEASES | 4/95 | 38.637 |
| 6 | 賴志政(1) | LONG COVID: AN INEVITABLE SEQUELA OF SARS-COV-2 INFECTION | Original Article |
J Microbiol Immunol Infect. 2023 Feb;56(1):1-9. | SCI | MICROBIOLOGY | 17/137 | 10.273 |
| 7 | 賴志政(5,C) | Clinical efficacy and safety of topical difamilast in the treatment of patients with atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials | Original Article |
Expert Rev Clin Pharmacol . 2022 Dec;15(12):1471-1478. |
SCI | PHARMACOLOGY & PHARMACY | 108/279 | 4.108 |
| 8 | 賴志政(4,C) | The impact of vitamin C-containing treatment on the mortality of patients with sepsis: A systematic review and meta-analysis of randomized controlled trials | Original Article |
Journal of Infection and Public Health . 2022 Dec;15(12):1514-1520. |
SCI | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | 27/210 | 7.537 |
| 9 | 翁子傑(1) 賴志政(3) |
Clinical outcomes, virological efficacy and safety of nitazoxanide in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials | Original Article |
Expert Review of Anti-Infective Therapy . 2022 Dec;20(12):1615-1622. |
SCI | PHARMACOLOGY & PHARMACY | 52/279 | 5.854 |
| 10 | 賴志政(5,C) | Effect of fluvoxamine on outcomes of nonhospitalized patients with COVID-19: A systematic review and meta-analysis | Original Article |
Journal of Infection and Public Health. 2022 Nov; 15(11): 1259–1264. | SCI | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | 27/210 | 7.537 |
| 11 | 賴志政(1) | The Clinical Efficacy and Safety of Anti-Viral Agents for Non-Hospitalized Patients with COVID-19: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials | Original Article |
Viruses.2022 Aug 2;14(8):1706. |
SCI | VIROLOGY | 14/37 | 5.818 |
| 12 | 賴志政(4) | The impact of COVID-19 on the epidemiology of non-airborne/droplet-transmitted notifiable infectious diseases in Taiwan: A descriptive study | Original Article |
Journal of Infection and Public Health. 2022 Sep;15(9):1001-1005. | SCI | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | 27/210 | 7.537 |
| 13 |
賴志政(10,C) |
Clinical effectiveness of branded versus generic piperacillin-tazobactam for treating severe community-acquired pneumonia |
Original Article |
Journal of Infection and Public Health. 2022 Sep;15(9):961-965. |
SCI |
PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH |
27/210 | 7.537 |
| 14 | 賴志政(4,C) | Comparison of clinically indicated replacement and routine replacement of peripheral intravenous catheters: A systematic review and meta-analysis of randomized controlled trials | Original Article |
FRONTIERS MEDIA SA. 2022 Aug 12;9:964096. | SCI | MEDICINE, GENERAL & INTERNAL | 53/172 | 5.058 |
| 15 |
賴志政(C) |
The effect of inhaled corticosteroids on the outcomes of patients with COVID-19: |
Original Article |
EXPERT REVIEW OF CLINICAL PHARMACOLOGY.2022, VOL. 15, NO. 5, 593–600 |
SCI |
PHARMACOLOGY& PHARMACY |
64/275 | 5.045 |
| 16 |
賴志政(C) |
The clinical efficacy and safety of mesenchymal stromal cells for patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials. |
Original Article |
J Infect Public Health. 2022 Aug;15(8):896-901 |
SCI | Infectious disease | 20/95 | 7.537 |
| 17 |
賴志政(C) |
Clinical effectiveness of branded versus generic piperacillin-tazobactam for treating severe community-acquired pneumonia |
Original Article |
J Infect Public Health. 2022 Jul 22;15(9):961-965 |
SCI | Infectious disease | 20/95 | 7.537 |
| 18 |
陳建安(1) |
Epidemiology of Aspergillosis in Cancer Patients in Taiwan |
Original Article |
Infect Drug Resist. 2022 Jul 13;15:3757-3766. |
SCI | PHARMACOLOGY & PHARMACY | 107/279 | 4.177 |
| 19 |
賴志政(1) |
The effect of intravenous immunoglobulins on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials |
Original article |
Expert Rev Anti Infect Ther. 2022 Jul 7:1-8 |
SCI | Pharmacology & Pharmacotherapy | 52/279 | 5.854 |
| 20 |
賴志政(C) |
Type of Oral Anticoagulant and Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for VTE |
Letter |
JAMA. 2022 Jul 5;328(1):78-79. |
SCI | Medicine, General & Internal | 3/172 | 157.35 |
| 21 |
賴志政(1) |
The impact of the overuse of short-acting β2-agonists on the risk of sepsis and septic shock |
Original article |
J Allergy Clin Immunol. 2022 Jul;150(1):75-81 |
SCI | Allergy | 17/162 | 14.29 |
| 22 | 賴志政(1) | Favipiravir-based treatment for outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials | Original article |
Expert Rev Clin Pharmacol. 2022 Jun;15(6):759-766. |
SCI | Pharmacology & Pharmacotherapy | 108/279 | 4.108 |
| 23 |
賴志政(C) |
The effect of inhaled corticosteroids on the outcomes of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials. |
Original article |
Expert Rev Clin Pharmacol. 2022 May;15(5):593-600 |
SCI | Pharmacology & Pharmacotherapy | 108/279 | 4.108 |
| 24 |
賴志政(C) |
Efficacy of melatonin in the treatment of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials |
Original article |
J Med Virol. 2022 May;94(5):2102-2107 |
SCI | Virology | 2/36 | 20.693 |
| 25 |
賴志政(1) |
The Impact of the Pay-for-Performance Program on the Outcome of COPD Patients in Taiwan After One Year |
Original article |
Int J Chron Obstruct Pulmon Dis. 2022 Apr 21;17:883-891 |
SCI | Respiratory system | 49/65 | 2.893 |
| 26 |
賴志政(1) |
COVID-19 associated with concomitant mucormycosis and aspergillosis. |
Case report |
J Microbiol Immunol Infect. 2022 Apr;55(2):353-354. |
SCI | Infectious disease | 15/95 | 10.272 |
| 27 | 賴志政(C) | Clinical efficacy and safety of novel lipoglycopeptides in the treatment of acute bacterial skin and skin structure infections: a systematic review and meta-analysis of randomized controlled trials | Original Article |
Expert Rev Anti Infect Ther. 2022 Mar;20(3):435-444 | SCI | Pharmacology & Pharmacotherapy | 52/279 | 5.854 |
| 28 |
賴志政(C) |
Clinical efficacy and safety of Janus kinase inhibitors for COVID-19: A systematic review and meta-analysis of randomized controlled trials | Original Article |
Int Immunopharmacol. 2021 Oct;99:108027. | SCI | Immunology | 59/162 | 5.714 |
| 29 |
賴志政(1) |
Clinical efficacy of antiviral agents against coronavirus disease 2019: A systematic review of randomized controlled trials | Review Article | J Microbiol Immunol Infect. 2021 Oct;54(5):767-775 | SCI | Infectious disease | 15/95 | 10.272 |
| 30 |
賴志政(1) |
Clinical efficacy and safety of remdesivir in patients with COVID-19: a systematic review and network meta-analysis of randomized controlled trials | Original Article |
J Antimicrob Chemother. 2021 Jul 15;76(8):1962-1968. | SCI | Infectious disease | 32/95 | 5.758 |
| 31 | 賴志政(C) | Clinical Efficacy of Cefoperazone-Sulbactam versus Piperacillin-Tazobactam in the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia. | Original Article |
Infect Drug Resist. 2021 Jun 16;14:2251-2258 | SCI | Infectious disease | 51/95 | 4.177 |
| 32 | 賴志政(1) | The Association between the Risk of Aortic Aneurysm/Aortic Dissection and the Use of Fluroquinolones: A Systematic Review and Meta-Analysis. | Original Article |
Antibiotics (Basel). 2021 Jun 10;10(6):697 | SCI | Pharmacology & Pharmacotherapy | 68/279 | 5.222 |
| 33 |
陳殿和(1) |
VALIDATION OF SHOCK INDEX FOR PREDICTING MORTALITY IN OLDER PATIENTS WITH DENGUE FEVER |
Original Article |
AGING CLIN EXP RES Vol 33/NO 03/P 635-640 |
SCI | GERIATRICS & GERONTOLOGY |
28/51 | 2.697 |
| 34 |
林高章(7,C) |
Mesenchymal stem cell-conditioned medium attenuates the retinal pathology in amyloid-β-induced rat model of Alzheimer's disease: Underlying mechanisms. |
Original Article |
Aging Cell. 2021 May;20(5):e13340. doi: 10.1111/acel.13340. Epub 2021 Mar 30. |
SCI | Aging | 2/35 | 9.304 |
| 35 |
賴志政(1) |
The impact of the coronavirus disease 2019 epidemic on notifiable infectious diseases in Taiwan: A database analysis | Original Article | Travel Med Infect Dis. 2021 Mar-Apr;40:101997 | SCI | Infectious disease | 7/95 | 20.441 |
| 36 |
賴志政(1) |
Clinical efficacy and safety of ceftobiprole in the treatment of acute bacterial skin and skin structure infection: a systematic review and meta-analysis of randomized controlled trials. | Original Article |
Expert Rev Anti Infect Ther. 2022 Jan;20(1):95-102 | SCI | Pharmacology & Pharmacotherapy | 52/279 | 5.854 |